ANK1 and neoplasm: Subclonal ANK1 mutation is related to adverse outcomes of CRC through increasing IL4I1, IDO1, IFNG and MAPK12, which may cause tumor immune escape through the accumulation of immunosuppressive cells such as regulatory T cells and myeloid derived suppressive cells.